At a glance
ClinicalIndex Comparison RecordN/ACompleted· 12 enrolled
Drug / intervention
EVP unflavoured +3 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomised, Crossover, Relative Bioavailability Study of Nicotine Delivered by an Electronic Vapour Product, a Nicotine Inhalator and a Conventional Cigarette
In Brief
A clinical study evaluating EVP unflavoured, EVP flavoured, and 2 other interventions for Healthy Volunteers. Completed, enrolled 12 participants across 1 site.
Detailed Summary
Electronic Vapour Products (EVPs) are a relatively new class of consumer products that are otherwise known as electronic cigarettes. These may look like conventional cigarettes but do not contain tobacco. The 'vapour' produced by such devices typically consists of humectants (propylene glycol or glycerol), nicotine, water, and flavours. This trial is to evaluate the pharmacokinetic profile of an EVP.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Volunteers
CountriesUnited Kingdom
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartDec 2013
First PostedJan 2014
Primary CompletionMay 2014
Study CompletionDec 2015
TodayJul 2026
First PostedJan 9, 2014
Enrollment StartDec 1, 2013
Primary CompletionMay 1, 2014
Study CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 12.5 years ago
Interventions
EVP unflavouredother
EVP flavouredother
Nicotine inhalatorother
15 mg nicotine Nicorette
Conventional cigaretteother